The Effect of Preanalytical Conditions on Blood-Based Inflammation Biomarkers

Thomas O'Donnell1, Stephanie Weinstein1, Yukiko Yano1

  • 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland 20850, United States.

PubMed
Summary

Blood inflammation biomarkers are reliable for diagnostic testing. Most proteins showed good stability across various preanalytical conditions, supporting their use in clinical settings.